In silico modeling predicts drug sensitivity of patient-derived cancer cells
Authors:
- Sandeep C PingleSPSandeep C Pingle
- Zeba SultanaZSZeba Sultana
- Sandra PastorinoSPSandra Pastorino
- Pengfei JiangPJPengfei Jiang
- Rajesh MukthavaramRMRajesh Mukthavaram
- Ying ChaoYCYing Chao
- Ila Sri BharatiIBIla Sri Bharati
- Natsuko NomuraNNNatsuko Nomura
- Milan MakaleMMMilan Makale
- Taher AbbasiTATaher Abbasi
- Shweta KapoorSKShweta Kapoor
- Ansu KumarAKAnsu Kumar
Open Access
- 21 May 2014
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 128
Abstract
Glioblastoma (GBM) is an aggressive disease associated with poor survival. It is essential to account for the complexity of GBM biology to improve diagnostic and therapeutic strategies. This complexity is best represented by the increasing amounts of profiling (“omics”) data available due to advances in biotechnology. The challenge of integrating these vast genomic and proteomic data can be addressed by a comprehensive systems modeling approach.Keywords
This publication has 33 references indexed in Scilit:
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulusScientific Reports, 2013
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotypeSystems and Synthetic Biology, 2009
- Personalizing medicine: a systems biology perspectiveMolecular Systems Biology, 2009
- In silico cancer modeling: is it ready for prime time?Nature Clinical Practice Oncology, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Identification of molecular subtypes of glioblastoma by gene expression profilingOncogene, 2003
- Mutations of the BRAF gene in human cancerNature, 2002